NCT Number: NCT01860274
Meshed Vein Graft Patency Trial - VEST
The study hypothesis is that a meshed conduit made of safen vein allows a better patency at mid-long term than a safen vein alone.
To test this hypothesis the investigators plan a prospective, randomized study, comparing grafts to the diagonal, in cases of vessel diameter under 1.5mm. A control angiography will be performed one year after the operation.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
European Hospital, Rome, Italy
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Clinical Indication for elective Coronary Artery Bypass Grafting with at least one vein graft
- Coronary artery with critical stenosis (over 70%)
Exclusion criteria
-
Treatment and study plan
Primary outcomes
-
Patency
Time frame: 6 to 12 months
Patency of graft at CT Scan
Secondary outcomes
-
Major Adverse Cardiac and Cerebrovascular Events (MACCE)
Time frame: 60 months
-
Vein graft lumen uniformity
Time frame: 6 to 12 months
Sponsors and collaborators
Lead sponsor
Cardiochirurgia E.H.
Other
Registry information
Official study title
External Mesh of Vein Grafts In Coronary Artery Bypass Grating: Early Patency and Clinical Outcome
Important dates
- Study start
- 2015
- Primary completion
- 2019
- Study completion
- 2020
- First posted
- May 22, 2013
- Registry last updated
- Mar 12, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
CES1 Carriers in the PAPI Study
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsImpact of Cardiac Rehabilitation on Patient Outcomes
NCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsA Sugar-Sweetened Beverage Reduction Intervention for Native American Men
NCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsSafety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
NCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details